Cannabis Europa Heads to London Amid €1.5 Billion European Market Surge

More than 70 international speakers and over 1000 delegates set to convene on London
next month for policy debates, high-level networking and the 2026 Business of Cannabis
Awards

LONDON, 15 April 2026 — Cannabis Europa, the leading B2B conference for the European
cannabis industry, today announced the full programme for its 2026 London edition. Taking
place at The Barbican on 26 and 27 May, the event will bring together more than 70
speakers — regulators, investors, clinicians and operators — for two days of main stage
debate, expert panels, an expanded exhibition floor and a new VIP experience.

The London 2026 edition arrives at a moment of considerable consequence for the sector.
Europe’s legal medical cannabis market is projected to surpass €1.5 billion according to
Prohibition Partners, regulatory frameworks are maturing, institutional capital is increasing,
and consolidation is reshaping the competitive landscape. Cannabis Europa London will be
the primary forum where those dynamics are debated, interrogated and acted upon.

Programme Highlights

Day one opens with a State of Play session on the United Kingdom, asking whether the
country can move from caution to action after nearly eight years of limited NHS access to
medical cannabis. A panel on UN drug policy and international law follows, examining
whether incremental progress under the 1961 Single Convention is sufficient or whether
meaningful patient access demands a more ambitious top-down rethink. A dedicated
session on workplace and driving law complexities will then examine the gap between legal
principle and operational practice for CBMP patients across roadside enforcement and HR
policy.

Day two opens with Europe’s telehealth crossroads, examining the regulatory push to
restrict online prescribing in Germany and its implications for operators, clinics and patients
across the continent. A panel on price compression follows, addressing the divergence
between collapsed German bulk prices and EU-GMP premium formats and the margin
strategies available to operators navigating a tightening market. A dedicated session on
cannabis and the gender health gap — addressing endometriosis, menopause and conditions long under-served by conventional medicine — takes centre stage mid-morning, alongside a closing panel interrogating whether Europe’s medical cannabis market is making a definitive shift from flower to pharmaceutical-grade formats.

‘Cannabis Europa exists because the industry’s most consequential conversations require
the right room,’ said Stephen Murphy, co-founder of Cannabis Europa. ‘The London 2026
programme reflects where the European market genuinely stands — more sophisticated
than ever before, consolidating, and demanding rigorous analysis.’

Confirmed Speakers

● Kristine Lütke – Former Member of the German Bundestag
● Martin Dickie – Co-Founder of Brewdog & CEO of Waterside
● Saphira Galoob – CEO, US Cannabis Roundtable
● Bryan Lanza – Former Communications Director, Trump’s Transition Team
● Raj Grover – CEO, High Tide
● Philip Schetter – CEO, Cantourage Group SE
● Tim Henley – Strategy Director, Medbud.wiki
● Dr Grace Blest-Hopley — Chief Science Officer at Hystelica
● Other speakers include senior figures from Fieldfisher, Saul Ewing LLP, Transform
Drug Policy Foundation and the Geneva Institute, among many others.

Exhibition, Awards & VIP Experience

The expanded exhibition floor will host leading operators and suppliers including Storz &
Bickel, Sanity Group, Curaleaf and Cantourage, with a secondary Greenhouse stage running
parallel sessions throughout both days. The 2026 Business of Cannabis Awards will be
presented on the main stage on 26 May, recognising the companies, clinicians and
advocates driving measurable progress across the industry.

A VIP programme runs across both days, comprising exclusive morning breakfasts, private
networking, dedicated meeting rooms and awards reception access.

Tickets are available online at cannabis-europa.com. For press accreditation, contact
press@cannabis-europa.com

Buy Tickets

About Cannabis Europa

Cannabis Europa is the leading B2B conference series for the European cannabis industry, produced by Prohibition Partners. Cannabis Europa London takes place on 26–27 May 2026 at The Barbican, London.

About Prohibition Partners

Prohibition Partners is the global leader in cannabis business intelligence. Its portfolio includes Cannabis Europa, Business of Cannabis, Cannabis Health News and the European Cannabis Report.

Media contact: Michael Hoban, Head of Marketing & Comms, Prohibition Partners –
michael@prohibitionpartners.com

Was this useful for you? Yes 0 No 0

Why not?